Recent Updates
Recently added Catalysts
EBS

Emergent BioSolutions to Participate in Series of Near-Term Investor Conferences

Key Takeaway: GAITHERSBURG, Md., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will participate in the following investor conferences during the third quarter and early portion of the fourth quarte

Full Press Release Details

GAITHERSBURG, Md., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will participate in the following investor conferences during the third quarter and early portion of the fourth quarter of 2018:
Three Part Advisors – 2018 Midwest IDEAS Investor Conference
Wells Fargo Securities – 2018 Healthcare Conference
Robert W. Baird & Co. – 2018 Global Healthcare Conference
Morgan Stanley – 16th Annual Global Healthcare Conference
September 12-14, 2018
Janney Montgomery Scott – Healthcare Conference 2018
September 17-18, 2018
Cantor Fitzgerald – Global Healthcare Conference 2018
Presentation dates and times will be updated on the Emergent website www.emergentbiosolutions.com under “Investors” as the information becomes available.
For these conferences, the company will be webcasting its presentation, which may include a discussion of the company's recent business developments as well as its most recently reported financial results and guidance. The webcasts will be available both live and by replay, accessible from the Emergent website.
About Emergent BioSolutions
Vice President, Investor Relations
Vice President, Corporate Communications
Last updated: Aug 17, 2018